Breaking News
Get 55% Off 0
🎈 Up Big Today: Find today's biggest gainers with our free screener
Try Stock Screener
Close

Teva Pharmaceutical Industries Ltd (TEVA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6,219 +44    +0.71%
18:46:33 - Delayed Data. Currency in ILS
Type:  Equity
Market:  Israel
ISIN:  IL0006290147 
S/N:  629014
  • Volume: 183,506
  • Bid/Ask: 6,219 / 6,220
  • Day's Range: 6,192 - 6,240
Teva 6,219 +44 +0.71%

TEVA Recent Sentiments

 
This page features our users' sentiments regarding the Teva Pharmaceutical Industries Ltd stock. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Dec 12, 2024 Rorr Ro   6175 +0.71%
Dec 11, 2024 אסתר כץ   6237 +0.29%
Dec 10, 2024 אבי פלד   6256 -0.59%
Dec 09, 2024 משה לביא   6186 +0.53%
Dec 09, 2024 Betzalel Weg   6171 -0.78%
Dec 09, 2024 david vaknin   6247 -0.45%
Dec 08, 2024 ביתו אונלי   6251 +0.51%
Dec 08, 2024 שלמה אהרוני   6241 -0.35%
Dec 08, 2024 אושרי אהרונוב   6370 -2.37%
Dec 06, 2024 munits a   6370 Dec 08, 2024 @ 6247 -1.93%
Dec 05, 2024 רפי מנטין   6394 -2.74%
Dec 04, 2024 אשר זרביב מהדרין...   6353 -2.11%
Dec 03, 2024 מוטי עמית   6034 +3.07%
Dec 03, 2024 David Okman   6089 Dec 08, 2024 @ 6247 +2.59%
Dec 02, 2024 מורדי אמזלג   6090 +2.12%
Dec 02, 2024 נתנאל גוזלן   6107 -1.83%
Dec 02, 2024 ישעיהו בקרמן   6116 Dec 08, 2024 @ 6247 +2.14%
Dec 01, 2024 Lior N   6110 +1.78%
Dec 01, 2024 Ariel Biton   6113 Dec 08, 2024 @ 6247 -2.19%
Dec 01, 2024   6090 +2.12%
Dec 01, 2024 יהושע קלויזנר   6096 Dec 08, 2024 @ 6247 +2.48%
Nov 28, 2024 דוד זכריה   5964 +4.28%
Nov 27, 2024 Aryekchlon Aryekahlon   6000 +3.65%
Nov 27, 2024 Itamar be   5999 Nov 27, 2024 @ 6008 -0.15%
Nov 26, 2024 david moshe   6029 -3.15%
Nov 26, 2024 P W   6013 +3.43%
Nov 25, 2024 שמוליק מחלב   6220 -0.02%
Nov 25, 2024 אורי צייטלין   6301 Nov 25, 2024 @ 6301 0.00%
Nov 24, 2024 חיים שפאשא   6290 -1.13%
Nov 21, 2024 אייל הלל   6348 Nov 24, 2024 @ 6306 +0.66%
Nov 20, 2024 ראובן חולי   6297 -1.24%
Nov 19, 2024 יגאל בן יעקב   6145 +1.20%
Nov 19, 2024 Tipsa Osakas   6151 Nov 24, 2024 @ 6306 +2.52%
Nov 18, 2024 ירון ברגר   6121 -1.60%
Nov 18, 2024 יעקב ברקוביץ   6118 +1.65%
Nov 18, 2024 אפי גבע   6133 +1.40%
Nov 18, 2024 שמשון ישראלי   6142 -1.25%
Nov 18, 2024 meir vanunu   6147 +1.17%
Nov 18, 2024 שירים שאני אוהב מיצל   6142 +1.25%
Nov 18, 2024 Ilan Aviram   6160 +0.96%
Nov 18, 2024 guy tamari   6189 -0.48%
Nov 17, 2024 Ram Weissman   6167 +0.84%
Nov 17, 2024 גבריאל אסור   6163 -0.91%
Nov 17, 2024 רמי מימון   6181 +0.61%
Nov 17, 2024 Simon Firouz   6204 +0.24%
Nov 13, 2024 אבי ארביב   6463 Dec 05, 2024 @ 6370 -1.44%
Nov 12, 2024 ניב מימון   6545 Dec 05, 2024 @ 6370 -2.67%
Nov 11, 2024 bnbn bnbn   6578 Dec 05, 2024 @ 6370 +3.16%
Nov 11, 2024 אלחנן אפרתי   6562 Nov 17, 2024 @ 6189 -5.68%
Nov 10, 2024 Moti Dagan   6476 Dec 05, 2024 @ 6370 -1.64%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Comments

Write your thoughts about Teva Pharmaceutical Industries Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alexey Knoroz
Alexey Knoroz Feb 19, 2020 21:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email